Gifts India Expo 2025 Wraps Up in Mumbai, Showcasing Trends in Gifting & Stationery
Mumbai (aharashtra) [India], June 18: The 31st edition of Gifts India Expo 2025 concluded successfully today at the Bombay Exhibition Centre, Mumbai, reaffirming its position as India's most celebrated and comprehensive exhibition for corporate gifting and stationery. Organized by RX India, the three-day event marked a milestone for the sector, drawing over 200 exhibitors and showcasing more than 700+ innovative products across 17 categories, with participation from over 15 countries. The expo once again proved to be a global platform for industry collaboration, creativity, and business innovation.
Inaugurated on June 12 by respected dignitaries including Shri Milind Barapatre, Joint Director & Head of Office, MSME Development & Facilitation Office, Mumbai, alongside senior officials from MSME, industry associations, and business leaders from top brands, the event set a high benchmark for excellence and engagement within the industry.
This year's edition featured a vibrant display of leading brands such as FNP, Confetti, Artdinox, FRIDO, Nasher Miles, and Vivanda. A major highlight on Day 1 was the live product launch of Nutovia's new range of gourmet flavoured peanut butters, which drew significant attention from visitors, buyers, and media.
The expo provided an immersive experience for professionals across industries, offering insights into the latest trends in corporate gifting, promotional merchandise, lifestyle stationery, and sustainable innovations. Thousands of visitors from India and abroad explored premium offerings, engaged in high-impact networking, and forged strategic partnerships that are expected to drive future growth in the sector.
Speaking on the event's successful conclusion, Ashna Gemini Sharan, Portfolio Director, RX India, said, 'We are proud to see the exceptional response to the 31st edition of Gifts India Expo. The enthusiasm of both our exhibitors and visitors reflects the dynamic transformation of India's corporate gifting industry. This platform not only highlights the convergence of business and celebration but also enables global and local brands to connect, co-create, and expand their reach in a growing market. RX India is committed to nurturing this growth and showcasing the best that the industry has to offer.'
Gifts India Expo 2025 ended on a high note, cementing its role as a catalyst for innovation, business development, and global connectivity in India's rapidly evolving gifting ecosystem.
RX is a global leader in events and exhibitions, leveraging industry expertise, data, and technology to build businesses for individuals, communities, and organizations. With a presence in 25 countries across 42 industry sectors, RX hosts approximately 350 events annually. RX empowers businesses to thrive by leveraging data-driven insights and digital solutions. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.rxglobal.com
About RX India:
RX India is a leading organizer of B2B trade exhibitions and events in India, serving as a catalyst for business growth, networking, and expansion opportunities. With a portfolio comprising ten events covering warehousing and logistics, printing, packaging, metal cutting & forming, automation, robotics, retail, and real estate, RX India provides unparalleled opportunities for businesses to connect, stay abreast of market trends, and access the latest products and technologies.
Headquartered in Gurgaon, the company offers comprehensive event coverage and tailored support with qualified teams across India. Since its inception in 2008, RX India has been committed to creating efficient B2B platforms, supporting local economies, and fostering diverse and sustainable businesses. Leveraging digital transformation strategies and a wealth of talent and intelligence, RX India extends its reach to a broader audience, covering a diverse range of industries and markets. With an impressive global outreach spanning 22 countries, RX India attracts both domestic and international participants, facilitating collaborations and market expansion.
As a major player in the B2B event business, RX India continually expands its event portfolios, penetrates new industrial sectors, and emphasizes technology to provide customers with more interactive experiences. Through innovation and customer-centric approaches, RX India aims to set the standard in the Indian exhibition industry and beyond, driving industry growth and business success.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
26 minutes ago
- Forbes
My Chemical Romance's Album Soars Nearly 3,000% In Sales
My Chemical Romance's deluxe Three Cheers for Sweet Revenge helps the band tie its all-time peak of ... More No. 2 on Billboard's Top Album Sales chart. MILAN, ITALY - NOVEMBER 21: My Chemical Romance posed backstage in Milan on November 21 2006. L-R Ray Toro, Frank Iero,Gerard Way, Mikey Way, Bob Bryar (Photo by Mick Hutson/Redferns) My Chemical Romance is enjoying quite the comeback on the Billboard charts this week. The emo band hasn't returned with a long-desired new album, but instead, a revamped version of its sophomore full-length Three Cheers for Sweet Revenge, which blasts back onto half a dozen tallies simultaneously. The exciting deluxe edition of the set reaches No. 1 on more than half of the rankings on which it appear, while at the same time, it just barely misses out on becoming the group's first champion on one highly competitive tally. Three Cheers for Sweet Revenge Returns at No. 2 Three Cheers for Sweet Revenge reenters the Top Album Sales chart at No. 2. Luminate reports that in the past tracking period, the decades-old set sold 37,000 new copies. The week before the deluxe edition was available, it sold just 1,200. So, the collection experienced an almost 3,000% gain in pure purchases from one frame to the next. My Chemical Romance Matches Its Own Career Peak As Three Cheers for Sweet Revenge returns to the Top Album Sales ranking, My Chemical Romance ties its highest placement ever on the list of the bestselling full-lengths and EPs of any style in the United States. The group previously missed out on a No. 1 by just one rung back in November 2006, when The Black Parade debuted at No. 2. The rockers have seen two other collections — Danger Days: The True Lives of the Fabulous Killjoys and May Death Never Stop You — stall at Nos. 8 and 9, respectively. Three Cheers for Sweet Revenge Reappears at No. 1 While it misses the throne on the Top Album Sales ranking by one space, Three Cheers for Sweet Revenge does reappear on the Vinyl Albums, Top Rock & Alternative Albums, Top Rock Albums, and Top Alternative Albums charts at No. 1. My Chemical Romance hits the summit for the first time on the vinyl tally and adds to its growing list of leaders on the other three genre-specific rankings. My Chemical Romance Hits the Billboard 200's Top 10 In the past tracking frame, Three Cheers for Sweet Revenge moved a total of 43,600 equivalent units, and more than half of those were actual sales. That figure is enough to bring the emo groundbreaker into the top 10 on the Billboard 200, where My Chemical Romance has now scored four wins and where the title also reaches a new high point.
Forbes
26 minutes ago
- Forbes
GM's $4 Billion Gamble - Gas Guzzlers Or Electric Future?
General Motors, a flagship of the U.S. auto industry for 117 years, has quietly shifted its bold electric-vehicle ambitions. Just a week ago, the company announced a $4 billion investment to ramp up production of gasoline-powered SUVs and trucks at plants in Michigan, Kansas, and Tennessee—aimed at countering flagging EV demand and mitigating U.S. tariffs. Lafayette - March 12, 2024: Chevrolet Tahoe 4WD Z71 display at a dealership. Chevy offers the Tahoe ... More in LS, LT, RST and Premier models. MY:2024 New President = new plans Once GM pledged to go 'all-electric by 2035', riding the momentum of the Inflation Reduction Act and Biden-era clean energy enthusiasm. But EV sales in the U.S. have softened, Washington's EV subsidies are under threat and tariffs are forcing auto companies to rethink their supply chains. Also, by this time, most everyone who had been thinking about buying an EV has bought one, insiders say. The novelty has worn off. Some have simply shrugged and gone back to either all-gas-powered vehicles, hybrids or PHEVS. GM will relocate full-size gas SUV and light-duty truck production to its Orion Assembly in Michigan, redirect the Chevrolet Blazer to Spring Hill, Tennessee, and bring the popular Chevy Equinox back to Fairfax, Kansas, reconfiguring plants that were previously set for EV output, Meanwhile, its Tonawanda, NY plant gets an $888 million investment to produce V‑8 engines—not electric motors. Why Now? Analysts Sam Abuelsamid (Telemetry) argue GM's 'all-electric by 2035' pledge was always conditional—dependent on generous federal EV incentives and solid consumer demand. With both eroding, GM is hedging its bets, and you can't blame them. The Trump administration further complicated matters with 25% tariffs on vehicles and parts from Mexico. By shifting production to U.S. facilities, GM avoids those costs—an immediate financial relief during a tumultuous market. GM says they're not abandoning EVs This isn't an EV abandonment, GM insists. CEO Mary Barra reaffirmed that an electric future remains central, but the company must remain 'responsive to where the customer is." At a recent Wall Street Journal event, she stressed that infrastructure limitations and consumer affordability still impede widespread EV adoption. Still, GM's U-turn complicates its narrative. Just days earlier, the company urged employees to lobby against California's EV mandate, describing it as disconnected from 'market realities' and threatening vehicle affordability. What are the broader implications? GM joins rivals like Volkswagen and Mercedes, which have scaled back their electrification timetables. Industry experts see this as recognition that while EVs are part of the future, they aren't (yet) the only future. Here's what GM's new position really means: For EV adoption - This signals government policy isn't enough. Automakers need stable incentives and reliable infrastructure to build real EV demand. For domestic jobs - Short-term, the gas engine investment creates U.S. manufacturing jobs and protects against import tariffs. Longterm? GM is now playing both offense and defense—building more ICE vehicles to stay profitable while maintaining EV capacity for when conditions improve. The bottom line is that GM's shift is pragmatic, not ideological or a declaration of 'Drill, baby, drill!' It's a response to market and policy uncertainty—but it also represents a retreat from the aspirational vision of a fully electric future.
Daily Mail
26 minutes ago
- Daily Mail
Over-the-counter medicine taken by MILLIONS linked to surging cases of liver damage - top pharmacists claims 'It's EXTREMELY dangerous'
A painkiller found in almost every British medicine cabinet could be quietly damaging people's livers, a leading pharmacist has warned. Paracetamol—used by millions daily to treat everything from headaches to fevers—is safe when taken correctly. But even slightly exceeding the recommended dose can cause permanent liver damage, says Dipar Kamdar, a pharmacist and fellow at Kingston University. 'While generally safe when used as directed, taking too much—even slightly—can be extremely dangerous for your liver,' she wrote this week in The Conversation. 'Even small overdoses, or combining paracetamol with alcohol, can increase the risk of serious harm. 'Always stick to the recommended dose and speak to a doctor if you find yourself needing pain relief regularly.' She explained that the danger comes from how the liver processes paracetamol. As it breaks down the drug, it produces a toxic by-product called NAPQI. Normally, this is neutralised by a protective substance in the body known as glutathione. But in high doses, the liver can become overwhelmed—leading to potentially life-threatening damage. 'However, in an overdose, glutathione stores become depleted, allowing NAPQI to accumulate and attack liver cells. This can result in acute liver failure, which can be fatal.' There is growing concern about the spiralling number of cases of liver disease. Diagnoses have surged by 40 per cent and deaths caused by liver disease have risen four-fold in the past two decades. Around 10,000 people a year die from it, with those aged 45 to 64 making up half. The British Liver Trust says 90 per cent of these can be prevented by lifestyle changes. There are two types of liver disease: alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease (formerly non-alcoholic fatty liver disease). Excess fat build-up in the liver can cause the organ to become inflamed. Over time, this may lead to scarring that limits liver function. Left untreated, it can result in end-stage liver disease, also known as cirrhosis. Liver disease often presents with few or no symptoms in its early stages, but as it progresses can cause fatigue, jaundice, abdominal pain and swelling in the legs and ankles. The liver filters toxins, produces clotting factors and regulates blood flow. When it fails, complications follow, which can result in death. The British Liver Trust estimates that 80 per cent of people living with metabolic dysfunction-associated steatotic liver disease are going undiagnosed—with as many as one in three suffering from some form of the condition. The pharmacist also warns that poor diet and unhealthy eating habits is a key contributor to metabolic dysfunction-associated steatotic liver disease. She advises against foods high in saturated fat, such as red meat, fried foods and processed snacks. While suggesting that 'diets rich in vegetables, fruit, whole grains, legumes, and fish may reduce liver fat and improve related risk factors such as high blood sugar and cholesterol. Other risk factors include lack of exercise, smoking and drinking alcohol. Mrs Kamdar says: 'The liver is a remarkably robust organ – but it isn't invincible. You can protect it by drinking alcohol in moderation, quitting smoking, taking medications responsibly, eating a balanced diet, staying active and keeping hydrated. 'If you notice any symptoms that may suggest liver trouble, such as ongoing fatigue, nausea, or jaundice, don't delay speaking to your doctor. The earlier liver problems are detected, the better the chance of successful treatment.'
